Sign in
4

Changes in Ownership

RenovoRx, Inc. Filed Acc 0001209191-22-052234

Options or other derivatives

  • Director acquired 25,099 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Diamond David Director 2022-10-01 Grant or award · Stock Option (right to buy) +25,099 25,099 D
Loading xslF345X03/doc4.xml…